Overview Dividends

(AME) Ametek - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0311001004

Instruments,Sensors,Power,Connectors,Motors,Components

Electrical Components & Equipment
Market Cap in USD: 45,087m

IPO / Inception: 1984-07-19
Return 12m vs S&P 500: -11.9%

EPS (Earnings per Share)

EPS CAGR: 8.96%
EPS Trend: 81.6%

Last SUE: 4.00
Qual. Beats: 17

Revenue

Rev. CAGR: 6.33%
Rev. Trend: 94.9%

Last SUE: 2.21
Qual. Beats: 2

Dividends

Dividend Yield	0.77%
Yield on Cost 5y	1.31%
Yield CAGR 5y	11.68%
Payout Consistency	92.0%
Payout Ratio	17.6%

Risk via 10d forecast
Volatility	20.3%
Value at Risk 5%th	30.1%
Relative Tail Risk	-9.82%

Reward TTM
Sharpe Ratio	-0.05
Alpha	-11.41
CAGR/Max DD	0.53

Character TTM
Hurst Exponent	0.323
Beta	0.792
Beta Downside	0.866

Drawdowns 3y
Max DD	23.04%
Mean DD	5.58%
Median DD	5.39%

Description: AME Ametek September 29, 2025

AMETEK (NYSE:AME) operates two primary divisions: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The EIG segment supplies advanced instrumentation across process, aerospace, power, and industrial markets, covering everything from oil-and-gas analytical tools to aerospace sensor suites. The EMG segment focuses on engineered medical components, precision motion-control products, specialty metals, and thermal-management systems, and also runs a network of aviation MRO facilities.

In fiscal 2023 the company generated approximately $7.4 billion in revenue, with the EIG division contributing roughly 55 % and EMG the remaining 45 %. Operating margins hovered near 15 %, reflecting strong pricing power in niche aerospace and medical-device markets. Recent quarterly results (Q3-2024) showed earnings per share of $2.10, beating consensus estimates by 8 %.

Key drivers for AMETEK include sustained defense-spending growth (U.S. defense budget up ~5 % YoY), expanding semiconductor capital-expenditure cycles that boost demand for high-precision test equipment, and aging-population trends that underpin medical-device consumption. Conversely, a slowdown in oil-and-gas capital spending could pressure the process-instrument sub-segment. For a deeper quantitative view, you may want to explore ValueRay’s detailed earnings model for AME.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.47b TTM) > 0 and > 6% of Revenue (6% = 429.9m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -1.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.75% (prev 11.10%; Δ -5.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.11 (>3.0%) and CFO 1.77b > Net Income 1.47b (YES >=105%, WARN >=100%)

Net Debt (2.31b) to EBITDA (2.16b) ratio: 1.07 <= 3.0 (WARN <= 3.5)

Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (231.7m) change vs 12m ago -0.24% (target <= -2.0% for YES)

Gross Margin 36.18% (prev 35.41%; Δ 0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 46.30% (prev 46.79%; Δ -0.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 23.01 (EBITDA TTM 2.16b / Interest Expense TTM 80.4m) >= 6 (WARN >= 3)

Altman Z'' 5.51

(A) 0.03 = (Total Current Assets 3.06b - Total Current Liabilities 2.65b) / Total Assets 16.18b

(B) 0.74 = Retained Earnings (Balance) 11.92b / Total Assets 16.18b

(D) 2.03 = Book Value of Equity 11.49b / Total Liabilities 5.66b

Total Rating: 5.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 80.59

1. Piotroski 6.50pt

2. FCF Yield 3.47%

3. FCF Margin 22.93%

4. Debt/Equity 0.26

5. Debt/Ebitda 1.07

6. ROIC - WACC (= 4.07)%

7. RoE 14.49%

8. Rev. Trend 94.86%

9. EPS Trend 81.63%

What is the price of AME shares?

As of November 26, 2025, the stock is trading at USD 197.22 with a total of 1,219,835 shares traded.
Over the past week, the price has changed by +3.85%, over one month by +5.61%, over three months by +6.45% and over the past year by +0.71%.

Is AME a buy, sell or hold?

Ametek has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AME.

Strong Buy: 10
Buy: 2
Hold: 5
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the AME price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	219.9	11.5%
Analysts Target Price	219.9	11.5%
ValueRay Target Price	216.4	9.7%

AME Fundamental Data Overview November 26, 2025

Market Cap USD = 45.09b (45.09b USD * 1.0 USD.USD)
P/E Trailing = 30.7918
P/E Forward = 26.3158
P/S = 6.2933
P/B = 4.2647
P/EG = 2.9081
Beta = 1.045
Revenue TTM = 7.16b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.16b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 1.10b USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.31b USD (from netDebt column, last quarter)
Enterprise Value = 47.39b USD (45.09b + Debt 2.75b - CCE 439.2m)
Interest Coverage Ratio = 23.01 (Ebit TTM 1.85b / Interest Expense TTM 80.4m)
FCF Yield = 3.47% (FCF TTM 1.64b / Enterprise Value 47.39b)
FCF Margin = 22.93% (FCF TTM 1.64b / Revenue TTM 7.16b)
Net Margin = 20.50% (Net Income TTM 1.47b / Revenue TTM 7.16b)
Gross Margin = 36.18% ((Revenue TTM 7.16b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 35.76%)
Tobins Q-Ratio = 2.93 (Enterprise Value 47.39b / Total Assets 16.18b)
Interest Expense / Debt = 0.82% (Interest Expense 22.5m / Debt 2.75b)
Taxrate = 17.09% (76.5m / 448.0m)
NOPAT = 1.53b (EBIT 1.85b * (1 - 17.09%))
Current Ratio = 1.16 (Total Current Assets 3.06b / Total Current Liabilities 2.65b)
Debt / Equity = 0.26 (Debt 2.75b / totalStockholderEquity, last quarter 10.53b)
Debt / EBITDA = 1.07 (Net Debt 2.31b / EBITDA 2.16b)
Debt / FCF = 1.40 (Net Debt 2.31b / FCF TTM 1.64b)
Total Stockholder Equity = 10.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 1.47b / Total Assets 16.18b)
RoE = 14.49% (Net Income TTM 1.47b / Total Stockholder Equity 10.14b)
RoCE = 15.99% (EBIT 1.85b / Capital Employed (Equity 10.14b + L.T.Debt 1.43b))
RoIC = 12.53% (NOPAT 1.53b / Invested Capital 12.24b)
WACC = 8.46% (E(45.09b)/V(47.83b) * Re(8.93%) + D(2.75b)/V(47.83b) * Rd(0.82%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 78.37% ; FCFE base≈1.66b ; Y1≈2.01b ; Y5≈3.31b
Fair Price DCF = 207.8 (DCF Value 47.84b / Shares Outstanding 230.2m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 81.63 | EPS CAGR: 8.96% | SUE: 4.0 | # QB: 17
Revenue Correlation: 94.86 | Revenue CAGR: 6.33% | SUE: 2.21 | # QB: 2

Additional Sources for AME Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle